Role of mitochondrial raft-like microdomains in the regulation of cell apoptosis by Garofalo, Tina et al.
1 23
Apoptosis
An International Journal on
Programmed Cell Death
 
ISSN 1360-8185
Volume 20
Number 5
 
Apoptosis (2015) 20:621-634
DOI 10.1007/s10495-015-1100-x
Role of mitochondrial raft-like
microdomains in the regulation of cell
apoptosis
Tina Garofalo, Valeria Manganelli,
Maria Grasso, Vincenzo Mattei, Alberto
Ferri, Roberta Misasi & Maurizio Sorice
1 23
Your article is protected by copyright and all
rights are held exclusively by Springer Science
+Business Media New York. This e-offprint is
for personal use only and shall not be self-
archived in electronic repositories. If you wish
to self-archive your article, please use the
accepted manuscript version for posting on
your own website. You may further deposit
the accepted manuscript version in any
repository, provided it is only made publicly
available 12 months after official publication
or later and provided acknowledgement is
given to the original source of publication
and a link is inserted to the published article
on Springer's website. The link must be
accompanied by the following text: "The final
publication is available at link.springer.com”.
THE ROLE OF SPHINGOLIPIDS AND LIPID RAFTS IN DETERMINING CELL FATE
Role of mitochondrial raft-like microdomains in the regulation
of cell apoptosis
Tina Garofalo • Valeria Manganelli •
Maria Grasso • Vincenzo Mattei • Alberto Ferri •
Roberta Misasi • Maurizio Sorice
Published online: 5 February 2015
 Springer Science+Business Media New York 2015
Abstract Lipid rafts are envisaged as lateral assemblies
of specific lipids and proteins that dissociate and associate
rapidly and form functional clusters in cell membranes.
These structural platforms are not confined to the plasma
membrane; indeed lipid microdomains are similarly
formed at subcellular organelles, which include endoplas-
mic reticulum, Golgi and mitochondria, named raft-like
microdomains. In addition, some components of raft-like
microdomains are present within ER–mitochondria asso-
ciated membranes. This review is focused on the role of
mitochondrial raft-like microdomains in the regulation of
cell apoptosis, since these microdomains may represent
preferential sites where key reactions take place, regulating
mitochondria hyperpolarization, fission-associated chan-
ges, megapore formation and release of apoptogenic fac-
tors. These structural platforms appear to modulate
cytoplasmic pathways switching cell fate towards cell
survival or death. Main insights on this issue derive from
some pathological conditions in which alterations of mi-
crodomains structure or function can lead to severe alter-
ations of cell activity and life span. In the light of the role
played by raft-like microdomains to integrate apoptotic
signals and in regulating mitochondrial dynamics, it is
conceivable that these membrane structures may play a role
in the mitochondrial alterations observed in some of the
most common human neurodegenerative diseases, such as
Amyotrophic lateral sclerosis, Huntington’s chorea and
prion-related diseases. These findings introduce an addi-
tional task for identifying new molecular target(s) of
pharmacological agents in these pathologies.
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Lipid rafts and cell apoptosis
Lipid rafts are a dynamic assemblage of sphingolipids,
cholesterol and proteins that dissociate and associate
rapidly and form functional clusters in cell membranes [1].
These clusters provide highly efficient lipid–protein mod-
ules, which operate in membrane trafficking and cell sig-
naling. Indeed, lipid rafts are thought to function as
platforms that sequestrate specific proteins, thus introduc-
ing and modulating cell signaling [2, 3]. A general function
of lipid rafts in signal transduction may be to allow the
lateral segregation of proteins within the plasma mem-
brane, providing a mechanism for the compartmentaliza-
tion of signaling components, concentrating certain
components in lipid rafts, including those of importance in
apoptosis, and excluding others [4–6].
They have been associated with several cell functions
[4–7], including cell death. In particular, the possibility that
lipid rafts could be involved in the complex framework
instructing the apoptotic cascade has been investigated in a
series of works carried out in diverse cell systems [8–10].
In fact, it has been suggested that lipid rafts could play a
key role in receptor-mediated apoptosis of T cells [11, 12].
This is apparently due to two events that follow the re-
ceptor engagement: (i) the recruitment of CD95/Fas [8, 12,
13] as well as tumor necrosis factor-family receptors [14]
to plasma membrane lipid rafts, and (ii) the recruitment of
specific proapoptotic Bcl-2 family proteins to mitochon-
drial ‘‘raft-like microdomains’’ [15, 16].
As a matter of fact, main insights on this issue derive
from some pathological conditions providing useful clues
on the fact that alterations of microdomains structure or
function can lead to severe alterations of cell activity and
life span. A good example in this context is represented by
the field of cancer research and the development of new
therapeutic strategies. In fact, the need to overcome the
rather poor outcomes of current cancer chemotherapy
stimulated the development of novel targets and drugs.
Since apoptotic triggering clearly represents the goal of
cancer therapy, the development of drugs that target lipid
rafts leading to the formation of clusters of apoptotic sig-
naling molecule-enriched rafts could offer new opportuni-
ties for therapeutic intervention in cancer therapy [17, 18].
Intracellular scrambling to mitochondria
The concept of ‘‘organelle scrambling’’ has emerged to
describe the intermixing of membranes that normally be-
long to different types of organelles, but apparently merge
together following apoptosis-mediated changes in mem-
brane traffic [19]. An example of this concept is the global
alteration in the organelle membrane traffic induced by the
prototypic death receptor CD95/Fas in physiologically
sensitive cells, such as activated T lymphocytes. Then, an
initial wave of enhanced endocytosis is followed by a
caspase-dependent movement of internal membranes to-
ward the cell periphery, that primarily involves secretory
and endosomal membranes, partially intermixed with mi-
tochondria [20] and presumably enhancing intercellular
communication [21].
Indeed, scrambling among different cell organelles, in-
cluding plasma membrane, endoplasmic reticulum (ER),
and ER–mitochondria associated membranes, as well as
lysosomal vesicles and Golgi apparatus, was also hy-
pothesized after triggering of death receptors [22]. The
importance of ER in the apoptotic cascade has been re-
cently investigated [23, 24]. For example, under ER stress
conditions, ER transmembrane receptors initiate the un-
folded protein response [25] and, if the adaptive response
fails, apoptotic cell death ensues. This response is associ-
ated with organelle remodeling and intermixing and is
implicated in the pathophysiology of several neurodegen-
erative and cardiovascular diseases [26].
It is well known that depletion of ER lumenal Ca2? is a
known inducer of ER stress; however, following the de-
pletion of ER Ca2?, calreticulin, PDI, BiP/GRP78, and
GRP94 escape ER retention and may translocate to the cell
surface [27]. The appearance of ER chaperones and
oxidoreductases on the plasma membrane corresponds to a
danger-associated molecular pattern (DAMP). Their pres-
ence on the cell surface leads to the recruitment of innate
inflammatory cells, following the interaction of surface
DAMPs with pattern-recognition receptors. Upon forma-
tion of a complex between these proteins, a potent ‘‘eat-
me’’ signal is generated and phagocytosis of calreticulin or
GRP94-bearing stressed cells is initiated, thus representing
an important element of the immunological response to
cancer.
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Furthermore, the potential implication of Golgi appara-
tus remodeling in apoptosis execution has been analyzed in
detail [28]. Notably, the Golgi apparatus participates to the
complex framework of subcellular intermixing activities
that lead to CD95/Fas-triggered apoptosis [20].
In the same vein, lysosomal organelles have been ana-
lyzed in different experimental settings to understand how
certain lysosomal cysteinyl proteases, e.g. cathepsins, may
contribute to the cross talk between endolysosomes and
mitochondria during apoptosis.
In the last decade, intense research has provided a
wealth of information on how death signaling engages
mitochondria, a process that also involves dynamic aspects,
such as fusion and fission of mitochondrial membranes,
which requires mitochondrial and cytosolic proteins, in-
cluding members of the Bcl-2 family [29].
However, mitochondria have been shown to be tightly
associated with elements of the ER [30–35] and these
membranes have been called ER–mitochondria contact
sites [36, 37]. Several observations suggested a connection
between ER and mitochondria in mitochondrial dynamics;
the most spectacular example being the fact that events of
mitochondrial fission are enriched at sites of ER–mito-
chondria crossovers [38]. For instance, the ER may provide
scaffold molecules required for the fission reaction. Al-
ternatively, the ER may physically constrict mitochondria,
priming them for division. This observation, although
purely phenomenological, unveils a relationship between
the ER and mitochondrial division, which can be explained
by multiple models. In addition, contacts between ER and
mitochondria may facilitate a variety of signalling pro-
cesses between the two organelles, including Ca2? and
phospholipid exchange [37, 39, 40]. Indeed, ER–mito-
chondria associations may impact on a diverse number of
physiological processes, including ATP production, au-
tophagy, protein folding in the ER, mitochondrial bio-
genesis, transport and apoptosis [37, 40–43].
Therefore, identification of proteins that operate at the
interface between mitochondria-associated membrane
(MAM) and mitochondria has become an active area of
research. The distance between the ER and mitochondria at
these contact sites is 10–30 nm [23]. Consequently, a
protein bridge, linking the ER/MAM to mitochondria could
be accommodated within this space. In this regard, most of
the lipid biosynthesizing enzymes that are enriched in
MAM, probably do not directly link the apposing mem-
branes. Typical proteins, which are enriched in MAM in-
clude the inositol-1,4,5-tris-phosphate receptor-1 (IP3R-1)
[44, 45], the sigma-1 receptor (Sigma-1R) [46], the dy-
namin-like protein-1 (DLP1/Drp1) [47], the oxidoreductase
Ero1 [48], the mitochondrial voltage-dependent anion
channel-1 (VDAC-1) [49] and calnexin [46, 50, 51].
However, it is not clear whether these proteins directly
tether the two organelles, whether they increase the sta-
bility of the association between the ER/mitochondria, or
just enhance processes mediated by these contacts. For
example, the IP3R-1 at the ER face of the MAMs is
bridged to VDAC-1 at the OMM (outer mitochondrial
membrane) by glucose-regulated-protein 75, a molecular
chaperone also present in the mitochondrial matrix [49].
Association of these proteins confers stability to the teth-
ering complex and allows the formation of a pore that fa-
vors Ca2? transfer from the ER to the mitochondria [49,
52].
The involvement of MAM in apoptosis process is
complex [53]. Cell death mediated by Fas ligand binding to
hepatocytes, HeLa cells and Jurkat T lymphoma [54, 55]
heavily relies on protein–protein interaction at the MAM
interface, thus highlighting the importance of MAM tethers
not only for mitochondrial metabolism, but also for pro-
grammed cell death.
Mitochondrial dynamics and morphology are modulated
by the formation of ER–mitochondria contacts [56]. For
instance, disruption of these contact sites and the corre-
sponding increase in mitochondrial fission/fragmentation,
are associated with the induction of apoptosis [57].
Apoptosis is also intimately connected to the calcium status
of mitochondria. The flow of calcium from the ER into
mitochondria promotes the oligomerization of Bax (Bcl-2-
like protein 4), a pro-apoptotic mitochondrial outer mem-
brane protein, and causes permeabilization of mitochon-
drial outer membranes. Consequently, cytochrome c is
released into the cytosol, where the caspase cascade is
activated and, ultimately, apoptosis is induced [58]. The
calcium-mediated activation of the mitochondrial fission
protein DLP1 also stimulates Bax oligomerization and in-
creases apoptosis [56, 59]. Taken together, these observa-
tions indicate that the formation of contact sites between
the ER and mitochondria is functionally linked to both
mitochondrial Ca2?, flow and apoptosis induction [60].
Hence, several actors can contribute to the propagation
of death signalling [19, 28, 61, 62] and, among these, are
also lipid rafts. These structural platforms seem to be not
merely confined to the plasma membrane but, as demon-
strated in various cell models, lipid rafts appear to con-
tribute to the propagation of death signalling and to
modulate cytoplasmic pathways switching cell fate towards
cell survival or death [22].
Indeed, lipid microdomains are similarly formed at
subcellular organelles, which include endoplasmic reticu-
lum, Golgi and mitochondria, named lipid raft-like mi-
crodomains [15, 63]. In addition, some components of lipid
raft-like microdomains have been detected within ER–
mitochondria contact sites.
Nevertheless, in brains of b-galactosidase knock-out
mice, GM1 reportedly accumulated in MAM, in detergent-
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resistant domains and triggered a calcium-mediated stress
response and apoptosis. In fact, treatment of b-gal-/- cells
with methyl b-cyclodextrin (MbCD), which efficiently
extracts GM1 from the MAMs, rescues opening of the
permeability transition pore (PTP), dissipation of the po-
tential, and apoptosis [52]. A similar outcome can be ob-
tained by silencing Mitofusin-2 (Mfn2, dynamin-related
protein), which underscores the importance of membrane
tethering in eliciting the apoptotic process. In particular,
Mfn2, a potent effector of mitochondrial fusion, is located
not only in the OMM, precisely in the MAMs, but it is also
present in the ER, albeit in low amounts [64]. Loss of
function or silencing of Mfn2 in MEFs and HeLa cells
increases the distance between ER and mitochondria with
consequent reduction of Ca2? flux at the MAMs [64], and
mitochondria-mediated cell death [52]. Together, these
results establish Mfn2 as a physical tether between ER and
mitochondrial membranes at the MAMs and emphasize the
reciprocal connection between the topology of MAMs and
their ability to control Ca2? flux [52, 64, 65].
These findings support the joined role of both proteins
and lipids, particularly GM1, in the regulation of Ca2? flux
at the MAMs/glycosphingolipid-enriched microdomains
and in Ca2?-dependent apoptosis. Thus, MAM have been
proposed to contain membrane microdomains that are en-
riched in cholesterol and gangliosides, similar to the de-
tergent-resistant lipid rafts of the plasma membrane [52,
66, 67]. Interestingly, the accumulation of lipid metabolism
enzymes on the MAM could be the reason for the forma-
tion of a glycosphingolipid enriched microdomain fraction
at the MAM [52]. This observation, together with the
identification of a special set of proteins associated with
these microdomains [63, 68], suggested that lipid synthesis
and exchange at the MAM generate an ER subdomain with
unique properties. Therefore, the existence of cholesterol-
and GM1-enriched microdomains in MAM, and the role of
these microdomains in regulating the association between
the ER and mitochondria, require further investigation.
In this scenario, raft-like microdomains might par-
ticipate not only in the organization of interorganelle pro-
tein networks, but also exert a role in the intercellular
communication associated with cell death, participating in
structural and biochemical remodeling in terms of struc-
tural modifications, i.e. their curvature changes, as well as
their fission process. In particular, previous works, in-
cluding ours, identified mitochondria as possible targets for
raft components and hypothesized that the rearrangement
of glycosphingolipids, may be involved in the mitochon-
drial remodeling leading to the completion of the apoptotic
cell death program [15, 69, 70].
Indeed, a trafficking of disialoganglioside GD3, con-
sidered as a paradigmatic component of lipid rafts, to mi-
tochondria has been reported [15, 71, 72].
GD3 traffic to mitochondria
Different trafficking pathways, leading to accumulation of
GD3 in mitochondria, were demonstrated in different cells
in response to various apoptotic inducers, including C2
ceramide [69], TNF-a [70] or anti-CD95/Fas administra-
tion [15].
Giammarioli et al. demonstrated that, during CD95/Fas-
mediated apoptosis, ezrin, a cytoskeletal protein, may di-
rectly interact with actin-dependent clustering of GD3
distributed in uropods of lymphoblastoid T cells [73].
Similary, actin cytoskeleton might also be implicated in the
stabilization of CD95/Fas clusters in lipid rafts [74]. Then,
cytoskeletal elements could act as concentrators of death
receptors, as well as drivers of GD3 traffic to the mito-
chondrion. How these proteins may interact with lipids to
regulate sorting between intracellular trafficking pathways
has been investigated in the last few years.
In this regard, some authors characterized the trafficking
of GD3 from the plasma membrane to mitochondria fol-
lowing TNF-a-exposure in rat hepatocytes, indicating that
GD3 mitochondrial targeting could depend on endosomal/
actin cytoskeleton vesicular trafficking through a Golgi/
endosomal network [70]. In fact, actin disruption and mi-
crotubule depolymerization by latrunculin A and nocoda-
zole prevented GD3 redistribution and interaction with
mitochondria, sparing sensitized hepatocytes to TNF-a-
exposure [70].
Although these data suggest the involvement of endo-
somal vesicle movement in the targeting of GD3 to mito-
chondria, it cannot discard a direct targeting of GD3 to
mitochondria resulting from the continuity and contact
between the Golgi/endoplasmic reticulum network with
mitochondrial membranes [45, 75].
On the basis of these observations, we hypothesized that
GD3 can proceed from the cell plasma membrane and/or
from trans Golgi network to the mitochondria via a mi-
crotubule-dependent mechanism. Thus, during early time
points following Fas ligation, microtubules may be used as
tracks to direct intracytoplasmic transport of lipid raft
glycosphingolipid(s) to mitochondria. The movement of
GD3 from plasma membrane may be instructed by its as-
sociation with cytoplasmic linker proteins-59 (CLIPR-59)
[76], a new CLIP-170-related protein, involved in the
regulation of microtubule dynamics and associated with
lipid rafts by a double palmitoylation on tandem cysteines
within the C-terminal domain [77]. Since CLIPR-59 is not
only associated with the plasma membrane, but is also
targeted to trans Golgi network membranes, it may reg-
ulate both plasma membrane and trans Golgi network in-
teractions via microtubules. Hence, CLIPR-59 may
facilitate rafts/microtubules interaction following anti-
CD95/Fas treatment, supporting the view that CLIPR-59 is
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involved in intracellular trafficking, acting as a chaperone
molecule allowing a fast and prompt interaction between
GD3 and cytoskeletal proteins. As microtubules are
assembled by polymerization of Tubulin hetero-dimers
composed of a- and b-tubulin [78], Sorice et al., showed a
direct GD3-tubulin interaction depending on its high affi-
nity for a/b-tubulin heterodimers, as confirmed by docking
analyses [76]. Microtubular network integrity and function
are required for T cell pro-apoptotic signaling, since low
doses of demecolcine, a microtubule assembly-disrupting
drug, impaired glycosphingolipid trafficking towards mi-
tochondria also hindering apoptosis execution. Thus, mi-
crotubules may represent the directional network by which
glycosphingolipids, which are key signaling molecules
during receptor-mediated apoptosis of T cells, can move
and re-distribute inside the cells. Once in the mitochondrial
membrane they could contribute to the cascade of events
leading to apoptosis execution and cell demise.
Numerous studies detected some components of lipid
raft-like microdomains within ER–mitochondria contact
sites [52]. In this respect, we recently identified PrPC, a
GPI-anchored glycoprotein, as a new interacting protein
component of mitochondrial raft-like microdomains in
lymphoblastoid T cells undergoing CD95/Fas-mediated
apoptosis. It indicates that raft components can undergo
intracellular re-localization via ER–mitochondria associ-
ated membranes and microtubular network [79, 80]. Hence,
we hypothesized that, following CD95/Fas triggering, mi-
crotubules could play key roles in the intracellular direc-
tional redistribution, as well as in the recruitment to the
mitochondrial compartment, of both glycosphingolipids
and protein raft components [79].
The importance of glycosphingolipids–protein mole-
cular interactions has already been suggested. In particular,
it has been hypothesized that ganglioside–protein interac-
tions could act as regulators of membrane organization,
leading to the creation of a platform for the recruitment of
specific effectors for membrane-trafficking events, includ-
ing autophagosome biogenesis [81]. During the autophagic
process, membrane trafficking and intermixing leads to the
formation of autophagosomes, but the origin of au-
tophagosomal membranes appears still unclear. Recently, it
has been suggested that autophagosomes form at the ER–
mitochondria contact site [82]. In this vein, our recent
studies provide evidence that gangliosides, i.e. GD3, could
participate to this intermixing activity thanks to their
molecular interaction with key molecules involved in au-
tophagosome biogenesis and maturation [83]. Hence,
considering the fact that several studies have shown that
classic apoptotic regulators can regulate autophagy [84],
our findings suggest that ganglioside GD3 may also play a
pivotal role in morphogenetic remodeling of autophago-
somes during the autophagic process.
Raft-like microdomains in mitochondria
Raft-like microdomains are envisaged as lateral assemblies
of specific lipids and proteins in mitochondrial membrane,
enriched in gangliosides and cholesterol (although with a
content lower as compared to plasma membrane), but with
a relatively low content of phospholipids. They have been
proposed to function in changes of mitochondrial mem-
brane potential, in mitochondrial network remodeling and
in mitochondrial fusion/fission processes. In addition, they
may contribute to cell polarization, mitochondrial oxida-
tive phosphorylation and ATP production and release of
apoptogenic factors. Thus, these dynamic structures con-
tribute to apoptotic process and represent preferential sites
on the mitochondrial membrane where some key reactions
can be catalyzed [13, 15]: indeed some molecules, in-
cluding VDAC-1 and the fission protein hFis1, are con-
stitutively present, whereas Bcl-2 family proteins,
including truncated Bid, t-Bid, and Bax, are recruited fol-
lowing CD95/Fas triggering [15]. Furthermore, during
apoptosis, cardiolipin (CL) may be present in raft-like
microdomains, where it acts as an activation platform for
caspase-8 traslocation on mitochondria, at contact sites
between inner and outer membranes, facilitating its self-
activation [16]. In addition, CL acts as the mitochondrial
receptor for Bid [85], providing specificity for targeting of
t-Bid to mitochondria, regulating the oligomerization of
Bax [86] and mobilization of cytochrome c.
Other groups have also suggested that proapoptotic
members of the Bcl-2 family associate with mitochondrial
fission sites and mitochondrial fission proteins during
apoptosis [87]. Since mitochondria fission includes a pro-
found mitochondria remodeling and changes of mito-
chondrial membrane curvature, it was suggested that
changes of lipid and glycolipid moieties could play a role
in the morphologic changes of mitochondria in cells un-
dergoing apoptosis. We found that, following apoptotic
stimulation, the molecules involved in mitochondrial fis-
sion processes are recruited to the mitochondrial raft-like
microdomains. In particular, as reported above, hFis1 ap-
pears to be constitutively included in these microdomains,
whereas DLP1 is recruited to raft-like microdomains only
after CD95/Fas triggering. Interestingly, the disruption of
rafts, for example, by MbCD, by fumonisin B1 (an in-
hibitor of ceramide synthase) or by [D]-PDMP (an inhibitor
of glucosyltransferase), leads to an impairment of fission
molecule recruitment to the mitochondria, a reduction of
mitochondrial fission and a significant reduction of apop-
tosis [88]. The process of mitochondrial fission has been
recently analyzed extensively. Proteins that are involved in
the fission process (e.g. DLP1, hFis1), are associated either
with cell proliferation, when daughter cells need their own
energy factories, or with cell death by apoptosis, when
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fission process precedes the release of apoptogenic factors
by mitochondria. For instance, it is well known that, fol-
lowing apoptotic stimulation, DLP1 is recruited to the
mitochondrial outer membrane, where it colocalizes with
Bax and Mfn2 at the fission sites [89, 90]. For example,
DLP1 function is required for apoptotic mitochondrial
fission and cytochrome c release [91]. In addition, it has
also been suggested that Optic Atrophy-1 (OPA1), a pro-
fusion dynamin-related protein involved in cristae remod-
eling, could represent a further actor participating in
mitochondrial changes during apoptosis [92–95]. However,
the submitochondrial localization of this protein appears
still controversial. Indeed, a differential localization of
different OPA1 isoforms has been observed. It has been
suggested that the 88 kDa isoform preferentially associates
with the outer membrane [96]. We found that this isoform
is present in raft-like microdomains and coimmunopre-
cipitates with hFis1 after apoptotic stimulation; we cannot
rule out the possibility that further unidentified molecules
could participate in the interaction between OPA1 and
hFis1 proteins. Finally, as mitochondria fission includes a
profound mitochondrial remodeling and changes of mito-
chondrial membrane curvature, it was suggested that
changes of lipid and glycolipid moieties could play a role
in the morphogenetic changes of mitochondria in cells
undergoing apoptosis. On this basis, lipid rafts may be
included in the complex molecular framework leading to
mitochondrial fission: their presence can provide catalytic
domains where unknown molecular associations and/or
cleavages could occur. The role of the ganglioside in this
multimolecular system could be to facilitate the transient
and local formation of inverted hexagonal structures in
mitochondrial membrane that undergo the fission process,
for example, modifying mitochondrial membrane curvature
and fluidity [88].
Mitochondria depolarization and cytochrome c release
are also dependent on raft-like microdomain integrity, since
the disruption of raft-like microdomains in isolated mito-
chondria by MbCD prevented mitochondria depolarization,
cytochrome c release and apoptosis execution after treat-
ment with GD3 or t-Bid, pro-apoptotic protein [15]. MbCD-
induced disruption of mitochondrial raft-like microdomains
impairs mitochondrial bioenergetics, increasing mitochon-
dria resistance to Ca2?-inducing swelling [97].
It is conceivable that GD3, by interacting with mito-
chondrial raft-like microdomains [13], may trigger specific
sequential events involved in the apoptotic program [98],
including changes of mitochondrial membrane potential
(MMP), mitochondrial fission associated changes and the
subsequent release of apoptogenic factors [13, 15, 99, 100].
Regarding the first, i.e., the modifications of MMP, both
hyperpolarization (early event) and depolarization (late
event) have been shown to occur in T cells [101–104]. It
has, in fact, been hypothesized that MMP alterations could
be associated with relocalization of GD3 to the mito-
chondria [15, 105]. The role of GD3 could be to enhance
the generation of reactive oxygen species (ROS) from the
complex III of the mitochondrial electron transport chain,
which triggers the mitochondrial permeability transition
pore opening, leading to the cyt c-dependent caspase 3
activation. Furthermore, selective depletion of GSH in
mitochondria sensitizes intact hepatocytes to GD3-induced
apoptosis by enhancing the oxidative stress caused by GD3
[106]. Furthermore, it could suppress the proton pumping
activity and/or the increase in small-conductance channels
[107], thus modifying mitochondrial membrane fluidity
and MMP.
Mitochondrial lipid microdomains may thus be consid-
ered essential activating platforms, where specific key re-
actions can take place and can be catalyzed, representing
smart and compelling interactors in determining cell fate.
Role of raft-like microdomains in neurodegenerative
diseases
Mitochondrial dysfunction is a common hallmark of aging-
related neurodegenerative diseases in humans, indeed,
neurons, characterized by high-energy demands, are highly
dependent on mitochondrial metabolism, being unable to
switch to glycolysis when mitochondrial oxidative phos-
phorylation is impaired [108].
In the light of the role played by raft-like microdomains
to integrate apoptotic signals and in regulating mitochon-
drial dynamics, both in physiological and in pathological
conditions [72], it is conceivable that this membrane
structures may play a role in the mitochondrial alterations
observed in the most common human neurodegenerative
diseases. Indeed, proteins involved in neurodegeneration
mechanisms that affect apoptotic processes and mito-
chondrial functionality, have been described as component
of lipid raft structures [109]. Among these, VDAC-1 is an
interesting example. This protein, imbedded in the outer
mitochondrial membrane, was described as a resident
protein of lipid rafts [110] and our previous data revealed
the localization of VDAC-1 in the mitochondrial raft-like
microdomains as reported above [15]. The four VDAC
isoforms were described as lipid sensors, since regulate
cholesterol content in the outer membrane of mitochondria
and, in turn, membrane lipid composition affects their
functionality [111 and references therein]. In addition, it
can also participate to mitochondrial membrane perme-
abilization, an apoptotic checkpoint in stress and patho-
logical conditions [111].
An in depth analysis performed on purified mitochon-
dria from copper, zinc superoxide dismutase (SOD1)-
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linked animal models for the familial form of amyotrophic
lateral sclerosis (fALS) indicated that misfolded forms of
active and inactive mutant SOD1s are localized onto the
cytoplasmic face of the outer membrane of spinal cord
mitochondria [112] and here bind directly to VDAC-1,
inhibiting its conductance and activity [113].
The direct interaction with VDAC-1 is a property only
of spinal cord mitochondria and no association of mutant
SOD1 was seen with purified brain mitochondria from the
same animals. This latter finding is consistent with previ-
ous data demonstrating that mutant SOD1 associates with
the cytoplasmic face of the outer membrane of mitochon-
dria in spinal cord, but not in other tissue types [112].
Moreover, mutant SOD1 binding to VDAC-1 is inversely
correlated with the level of hexokinase-I, a known partner
that binds to VDAC-1 exposed on the cytoplasmic mito-
chondrial surface [113], with hexokinase-I accumulating to
much higher level in brain than in spinal cord
mitochondria.
The mutant SOD1–VDAC-1 interaction, as mentioned,
compromises VDAC-1 conductance and this mutant SOD1
property may offer a mechanistic explanation for alter-
ations of mitochondrial electron transfer chain complexes
activity and the capacity to consume oxygen and synthesize
ATP previously reported in both ALS patients and in ex-
perimental models for the pathology [114 and references
therein].
DLP1, as above described, is recruited in mitochondrial
lipid raft-like microdomains specifically after apoptotic
stimuli [88], where interacts with GD3, regulating the
mitochondrial morphogenetic changes during fission pro-
cesses. In this regard, in literature are present several data
indicating a disregulation of DLP1 in ALS experimental
models that could partially justify mitochondrial frag-
mentation observed in the same models [114].
In particular, several works describe morphological al-
terations that are reminiscent of fragmentation in mito-
chondria of cultured cells and mice expressing fALS-
linked mutant SOD1 [112, 115, 116]. Moreover, changes in
the expression levels of proteins modulating mitochondrial
dynamism have been observed in a cellular model of the
disease [116]. Bossy–Wetzel’s group described mitochon-
drial fragmentation induced by mutant SOD1 in primary
spinal cord motor neurons co-cultured with spinal cord
astrocytes [117]. Furthermore, the same authors rescued the
neurons from mutant SOD1-induced mitochondrial frag-
mentation and cell death restoring the fission and fusion
balance by the expression of a dominant-negative mutant
of DLP1 [117].
Raft like-microdomains are also present in the close
contact and juxtaposition sites through which mitochondria
and ER communicate [118 and references therein]. These
contact sites are involved in the collaborative production of
lipids and calcium homeostasis [37, 39, 40]. Indeed, close
associations between both organelles enhance the interor-
ganelle phospholipid transport [53], but also the transport
of other lipids, such as cholesterol [119] and sphingolipids,
supporting the metabolism of ceramide in cell cycle, cell
differentiation and apoptosis [120]. In addition to promote
lipid transfer, MAMs are also involved in Ca2? ions ex-
change between ER and mitochondria [118]. Recently,
several ER or mitochondria bound proteins have been de-
scribed to play an important role in maintaining the close
relationship between ER and mitochondria [118]. Intrigu-
ingly, these proteins include proteins involved in the
pathogenesis of ALS, such as Sigma1 Receptor (Sig1R),
Erlin2 and vesicle-associated membrane protein-associated
protein B (VAPB) [121, 122], that have been described as
MAM residents [63, 68].
Indeed, mutations in the genes coding for the proteins
Sigma1R and Erlin2 are related to a juvenile form of ALS
and mutation in gene coding for VAPB is responsible of
type-8 ALS [121, 122].
Loss of Sig1R leads to abnormal ER morphology and
mitochondrial abnormalities and depletion of Sig1R
destabilizes lipid rafts and calcium mobilization in a motor
neuronal cell line, confirming the crucial role of Sig1R in
lipid rafts and intracellular calcium homeostasis [123].
Moreover, recent papers from Miller’s group described the
physical interaction between VAPB and protein tyrosine
phosphatase interacting protein 51 (PTPIP51) localized on
the outer mitochondrial membrane and how this interaction
impacts on cytosolic and mitochondrial calcium handling.
Recently, the same authors reported that both wild type and
fALS-linked mutant transactive response DNA binding
protein 43 (TDP43) alter ER-Mito cross talk, perturbing
specifically VAPB–PTPIP51 interaction [124] both in vivo
and in vitro. TDP43 perturbs VAPB–PTPIP51 interaction
modifying the activity of glycogen synthase kinase-3b
(GSK3b), a kinase involved in ALS pathology [125] and
recruited in the active form within neuronal lipid rafts
[126]. Inhibition of GSK3b activity prolongs survival and
improves motor performances of SOD1-linked fALS
transgenic mice, partially blocking the CD95/FAS-medi-
ated extrinsic apoptotic pathway [125].
GSK3b is also recruited within neuronal lipid rafts in a
mouse model for Huntington disease and, as in ALS
transgenic mice, treatment of primary neurons with GSK3b
inhibitors reduces neuronal death [127]. This kinase is
implicated in regulating mitochondrial dynamics and
metabolism, affecting DLP1 phosphorylation and VDAC-1
function [128]; several papers showed mitochondrial loss,
abnormal mitochondrial dynamics in HD patients and
models for the disease [129, 130].
Huntingtin (Htt) has been described associated with
lipid rafts isolated from mouse brains and mutant Htt from
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presymptomatic Huntington’s disease knock-in mice is
more strongly associated with rafts than wild type. This
association, as mentioned, is accompanied by a significant
increase in raft-associated GSK-3b, which coincides with
apoptotic damages [127]. Interestingly, other authors de-
scribed the segregation of the mutant Htt in the membrane
lipid raft in an in vitro HD model, where polyQ-expanded
protein interacts with NADPH oxidase membrane subunit,
gp91, and facilitates the activation of the enzyme [131].
These data were confirmed in vivo by Valencia and col-
leagues [132]. The authors described the relevance of the
mutant Htt-induced activation of NADPH oxidase at lipid
raft in generating mitochondrial oxidative stress.
The polyQ-expanded protein triggers mitochondrial
fragmentation in different models for the disease [133 and
references therein]. This toxic property comes out from the
increased activity of DLP1 triggered by the direct inter-
action of this protein with mutant Htt [134]. The recent
data by Guo and colleagues [135] confirmed the key role of
this aberrant interaction, indeed, the authors showed that
the selective inhibition of DLP1 in cells from HD patients
and in mouse models for the pathology hampers the mutant
Htt induced neurodegeneration.
Our group has described in lymphoid cells from HD
patients the localization of mutant Htt in the mitochondrial
raft-like microdomains [136]. The presence of mutant Htt
in mitochondrial raft-like microdomains is closely related
to the recruitment in these areas of apoptotic factors be-
longing to the Bcl-2 family, such as Bak, Bax, and t-Bid
and this condition evokes in HD cells an increased sus-
ceptibility to apoptotic stimuli. Furthermore, mutant Htt
colocalizes with DLP1 and interestingly this colocalization
takes place in absence of apoptotic stimuli [136], therefore,
mutant Htt is able to attract DLP1 onto outer mitochondrial
membrane. Once again the mitochondrial raft-like mi-
crodomains play a key role in integrating the toxicity of
proteins responsible for neurodegenerative diseases with
key factors for mitochondrial function. Indeed, the treat-
ment of lymphoid cells from HD patients with compounds
that perturb raft composition, such as fumonisin B1 or
methyl-b-cyclodextrin, inhibited mitochondrial apoptotic
pathway induced by staurosporin as well as metabolic and
morphological damages of mitochondria observed in this
experimental model [136].
In the light of these several evidences, being central the
metabolism of cholesterol in regulating the physiology of
rafts, this metabolic pathway might play a key role in
neurodegenerative processes described in both ALS and
HD, and indeed in both pathologies are described distur-
bances in lipid metabolism [137] and, at least in animal
models, the high-energy diets have a relevant impact in the
progression of the disease [138].
Another relevant example of a key role of lipid rafts in
neurodegenerative diseases is represented by prion-related
diseases, also know as trasmissible spongiform en-
cephalopathies. Prions are infectious pathogens that cause a
group of invariably fatal neurodegenerative diseases af-
fecting humans and other mammalian species, mediated by
a novel mechanism [139]. They are able to acquire alter-
native conformations that become self-propagating [140].
In fact, prion protein (PrP) consists of two isoforms, one is
a host-encoded cellular isoform (PrPC) and the other is an
abnormal protease-resistant pathogenic isoform (PrPSc), of
which the latter is a causative agent of prion disease [140].
Table 1 Functions of lipid-enriched microdomains related to cell apoptosis
Microdomains Function Functional example
Plasma membrane rafts • Signal transduction processes
• Catalyze molecular interactions
• Death receptor signaling
• Apoptosis signaling compartmentalization
Golgi microdomains • Organelle scrambling • Trafficking and sorting
• Organelle reshaping
ER microdomains • Organelle scrambling
• Organelle cross talk
• ER stress
• Unfolded protein response
MAM microdomains • Recruitment of Ca2? channels
• Lipid homeostasis
• Ca2? signalling
• PtdSer and PtdEtn enzymes regulation
• Cholesterol esterification
Mitochondrial raft-like microdomains • Changes of curvature
• Recruitment of proapoptotic factors
• Recruitment of fission molecules
• Mitochondrial network remodeling
• Changes of mitochondrial membranes potential
• Cyt c release, Bak/Bax oligomerization
• Cardiolipin exposure on outer membrane,
Caspase-8 recruitment
• Mitochondrial fusion/fission process
ER endoplasmic reticulum, MAM mitochondria-associated membrane, PtdSer phosphatidylserine, PtdEtn phosphatidylethanolamine, Cyt c
cytochrome c
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Like other GPI-anchored proteins, most of PrPC, as well as
PrPSc, were found in lipid rafts of the neural plasma
membrane and lymphocytes [141], which are also enriched
in several cytoplasmic proteins, including tyrosine kinases
[142]. This localization is required for conversion of PrPC
to the transmissible spongiform encephalopathy-associated
protease-resistant isoform [143, 144]. The refolding pro-
cess of PrPC into PrPSc is generally accompanied by in-
crease in b-sheet structure and a propensivity to aggregate
into oligomers [140].
Several studies suggested that PrPC is also involved in
the regulation of presynaptic copper concentration, intra-
cellular calcium homeostasis, lymphocyte activation, as-
trocyte proliferation, and cellular resistance to oxidative
stress [145, 146]. Recent studies show the involvement of
PrPC in apoptotic signaling pathways [147]. In this context
Mattei et al. [79] showed that CD95/Fas triggering induced
a redistribution of PrPC to the mitochondria of T cells via a
mechanism that brings into play microtubular network in-
tegrity and function. Indeed, when we analyzed the PrPC
Fig. 1 Schematic drawing
depicting the intracellular traffic
of raft-like microdomain
components to mitochondria
and their possible role in the
apoptotic cascade. Bax Bcl-2-
like protein 4, CL cardiolipin,
CLIPR-59 cytoplasmic linker
proteins-59, Chol cholesterol,
DISC death-induced signaling
complex, DLP1 dynamin-like
protein-1, ER endoplasmic
reticulum, MAM mitochondria-
associated membrane, t-Bid
truncated Bid, VDAC-1 voltage-
dependent anion channel-1
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intracytoplasmic trafficking in CD95/Fas treated cells, we
found that microtubular network-perturbing agent de-
mecolcine impaired either mitochondrial re-localization of
PrPC or apoptosis induction. PrPC was redistributed to
mitochondrial raft-like microdomains, as well as at ER–
mitochondria associated membranes, as revealed by im-
munoelectron microscopy observations. The analysis of the
mitochondria swelling profile pointed to a dose-dependent
effect of recPrPC in inducing the increase of mitochondrial
membrane potential (i.e., hyperpolarization), followed by
the ‘‘typical’’ loss of mitochondria membrane potential
(i.e., depolarization) and the release of apoptogenic factors,
such as cytochrome c. In particular, it was suggested that
lipid rafts could contribute to define the metabolic fate of
PrPC. Indeed, if raft-embedded PrPC is part of the complex
framework normally contributing to the death of the cell, a
defective trafficking of PrPC from and toward lipid rafts
could also affect normal PrPC catabolism, also leading to
the formation of the 17-kDa polypeptide hydrolysis to form
the PrP 27-30 scrapie isoform.
Conclusion remarks
Raft-like microdomains are small dynamic components of
mitochondrial membrane, which may trigger specific key
events involved in the apoptogenic program, including
mitochondria hyperpolarization, fission-associated chan-
ges, megapore formation and release of apoptogenic factors
(Table 1).
ER–mitochondria associated membranes have been also
proposed to contain membrane microdomains that are en-
riched in cholesterol and gangliosides, similar to the de-
tergent-resistant lipid rafts of the plasma membrane. We
suggest that these microdomains at the ER–mitochondria
contact site may play a pivotal role in trafficking of key
molecules involved in the organization of interorganelle
protein networks as well as in the intercellular communi-
cation associated with cell death.
Thus, lipid raft components can exert their regulatory
activity in apoptosis execution at three different levels:
(i) in the DISC formation at the plasma membrane; (ii) in
the intracellular redistribution at cytoplasmic organelles,
and, (iii) in the structural and functional mitochondrial
modifications associated with apoptosis execution (Fig. 1).
In the light of the role played by raft-like microdomains
to integrate apoptotic signals and in regulating mitochon-
drial dynamics, both in physiological and in pathological
conditions, it is conceivable that these membrane structures
may play a role in the mitochondrial alterations observed in
some of the most common human neurodegenerative dis-
eases, such as ALS, Huntington’s chorea and prion-related
diseases. All these findings may introduce an additional
task for identifying new molecular target(s) of pharmaco-
logical agents in these pathologies. For instance, non-toxic
semisynthetic cyclodextrins, which are widely used in vitro
and in vivo as drug carriers, could be taken into consid-
eration for their raft-targeted activity. Hence, on the basis
of the results reported above, molecularly targeted therapy,
inhibiting the interaction of key molecules with mito-
chondrial raft-like microdomains, may be proposed.
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